Mural Oncology plc (MURA) Stock
MURA is no longer traded. Mural Oncology was delisted from the Nasdaq in December 2025.
Prices on this page are historical; the last trade was December 3, 2025 at $2.04.
Mural Oncology stock price history
MURA final trading statistics
- Final close
- $2.04
- Final trading day
- Dec 3, 2025
- Market cap at delisting
- $35.38M
- Shares outstanding
- 17.34M
- Final 52-week range
- $0.95 – $4.74
- Avg. volume (final 3 mo.)
- 171,610
- All-time high (split-adj.)
- $6.01 · Dec 2023
- All-time low (split-adj.)
- $1.00 · Apr 2025
- Return since IPO
- -46.3%
- Beta
- 2.96
- Book value / share
- $3.19
- Price / book
- 0.64
Mural Oncology annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$128.5M | -$7.58 |
| FY2023 | $0.00 | -$207.4M | -$3.57 |
| FY2022 | $0.00 | -$189.8M | — |
| FY2021 | $0.00 | -$175.4M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Mural Oncology plc
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland. As of December 4, 2025, Mural Oncology plc operates as a subsidiary of XOMA Royalty Corporation.
Mural Oncology stock FAQ
What happened to Mural Oncology stock?
Mural Oncology stock was delisted from the Nasdaq. Its final close was $2.04 on December 3, 2025.
Is MURA stock still trading?
No. MURA was delisted from the Nasdaq in December 2025 and no longer trades on a U.S. exchange.
What was the last price of MURA stock?
MURA closed at $2.04 on its final trading day, December 3, 2025, for a market value of about $35.38M.
What were Mural Oncology's revenue and earnings in its last full fiscal year?
Mural Oncology reported revenue of $0.00 and net income of -$128.5M in fiscal 2024, its last full year as a public company.
When did Mural Oncology go public?
Mural Oncology plc stock began trading on November 16, 2023.